Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

10 structures for P05455

Entry ID Method Resolution Chain Position Source
1OWX NMR - A 225-334 PDB
1S79 NMR - A 105-202 PDB
1S7A NMR - A 1-103 PDB
1YTY X-ray 229 A A/B 1-194 PDB
1ZH5 X-ray 185 A A/B 1-194 PDB
2VOD X-ray 210 A A/B 4-194 PDB
2VON X-ray 210 A A/B 4-194 PDB
2VOO X-ray 180 A A/B 4-194 PDB
2VOP X-ray 280 A A 4-194 PDB
AF-P05455-F1 Predicted AlphaFoldDB

224 variants for P05455

Variant ID(s) Position Change Description Diseaes Association Provenance
CA1959089
rs546772759
2 A>T No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA1959091
rs747161057
4 N>D No ClinGen
ExAC
TOPMed
gnomAD
rs776632185
CA1959093
6 D>G No ClinGen
ExAC
gnomAD
rs1438499171
CA348875637
7 N>D No ClinGen
gnomAD
CA348875716
rs1273050684
10 M>V No ClinGen
gnomAD
rs146485470
CA1959094
12 A>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA1959095
rs367922508
13 L>M No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1297190319
CA348875831
15 A>S No ClinGen
gnomAD
rs1352326179
CA348875962
19 H>Y No ClinGen
TOPMed
rs1318082149
CA348879025
26 G>S No ClinGen
gnomAD
CA348879052
rs1318117371
27 D>N No ClinGen
TOPMed
CA348879113
rs1252719505
29 N>D No ClinGen
TOPMed
CA1959115
rs769907654
COSM3787890
29 N>S pancreas [Cosmic] No ClinGen
cosmic curated
ExAC
TOPMed
gnomAD
rs566356422
CA1959117
32 R>W No ClinGen
ExAC
TOPMed
gnomAD
CA1959118
rs771484976
33 D>N No ClinGen
ExAC
gnomAD
rs905545381
CA59566712
34 K>R No ClinGen
TOPMed
CA59566715
rs267599002
39 Q>H No ClinGen
Ensembl
rs1374635098
CA348879470
39 Q>R No ClinGen
TOPMed
CA1959119
rs774515446
41 K>T No ClinGen
ExAC
gnomAD
TCGA novel 41 K>missing Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA348879641
rs1290474636
45 G>A No ClinGen
TOPMed
gnomAD
CA59566730
rs3191574
48 P>S No ClinGen
Ensembl
CA59566746
rs911514709
53 I>T No ClinGen
gnomAD
CA1959122
rs532347388
53 I>V No ClinGen
1000Genomes
ExAC
gnomAD
rs1358069216
CA348879934
56 N>K No ClinGen
gnomAD
rs918728303
CA59566801
60 R>C No ClinGen
TOPMed
gnomAD
CA59566802
rs891627030
COSM1009367
60 R>H Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
gnomAD
CA348880133
rs1333146440
63 T>A No ClinGen
gnomAD
rs1336724784
CA348880156
64 D>E No ClinGen
gnomAD
rs774983377
CA348880199
CA1959137
66 N>K No ClinGen
ExAC
gnomAD
rs772605830
CA1959138
68 I>T No ClinGen
ExAC
TOPMed
gnomAD
CA59566821
rs1009985222
71 A>V No ClinGen
TOPMed
rs1343007959
CA348880301
73 S>G No ClinGen
gnomAD
rs548069992
CA1959141
77 A>T No ClinGen
1000Genomes
ExAC
gnomAD
CA1959142
rs753217349
78 E>Q No ClinGen
ExAC
gnomAD
CA1959143
rs761453238
79 L>F No ClinGen
ExAC
TOPMed
gnomAD
CA348880437
rs761453238
79 L>V No ClinGen
ExAC
TOPMed
gnomAD
rs141623414
CA1959146
80 M>I No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs765070949
CA1959145
80 M>L No ClinGen
ExAC
TOPMed
gnomAD
rs765070949
CA1959144
80 M>V No ClinGen
ExAC
TOPMed
gnomAD
CA348880614
rs1439034558
84 E>D No ClinGen
gnomAD
rs568279000
CA1959148
93 P>S No ClinGen
1000Genomes
ExAC
gnomAD
CA348880964
rs751375349
94 S>C No ClinGen
ExAC
TOPMed
gnomAD
rs751375349
CA1959149
94 S>G No ClinGen
ExAC
TOPMed
gnomAD
CA348881048
rs1396770481
96 P>L No ClinGen
gnomAD
rs1159787253
CA348881030
96 P>S No ClinGen
TOPMed
CA1959150
rs756264443
103 E>G No ClinGen
ExAC
TOPMed
gnomAD
rs1400085380
CA348881411
107 D>Y No ClinGen
gnomAD
rs749319622
CA1959152
108 V>L No ClinGen
ExAC
gnomAD
CA1959153
rs537120356
110 N>S No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA59566906
rs879196529
113 V>I No ClinGen
Ensembl
CA1959156
rs377101371
114 Y>F No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA348881804
rs1220189594
115 I>M No ClinGen
gnomAD
CA1959157
rs557065020
115 I>V No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs757444172
CA1959193
120 T>A Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1183288270
CA348882409
121 D>G No ClinGen
gnomAD
rs887376306
CA59567510
121 D>Y No ClinGen
Ensembl
rs1236503677
CA348882458
122 A>G No ClinGen
TOPMed
CA348882555
rs1254474557
125 D>N No ClinGen
gnomAD
CA1959194
rs372066287
127 I>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA348882660
rs1558971269
127 I>R No ClinGen
Ensembl
TCGA novel 129 E>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA1959195
rs200789540
131 L>I No ClinGen
ExAC
TOPMed
gnomAD
rs1392147580
CA348882897
133 D>E No ClinGen
TOPMed
rs1558971287
CA348882877
133 D>N No ClinGen
Ensembl
rs1573960351
CA348882931
135 G>C No ClinGen
Ensembl
rs147074057
CA1959196
136 Q>* No ClinGen
ESP
ExAC
gnomAD
rs1359864396
CA348882972
137 V>I No ClinGen
gnomAD
rs747558417
CA1959198
140 I>T No ClinGen
ExAC
gnomAD
rs376401398
CA1959199
147 H>P No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA1959200
rs376401398
147 H>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs546270676
CA1959201
149 A>S No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA348883335
rs546270676
149 A>T No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA1959202
rs769419286
150 F>S No ClinGen
ExAC
gnomAD
TCGA novel 151 K>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 152 G>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1311333446
CA348883600
153 S>T No ClinGen
gnomAD
CA348883630
rs1558971367
154 I>T No ClinGen
Ensembl
CA348883619
rs1469063925
154 I>V No ClinGen
gnomAD
CA348883680
rs1278992679
155 F>L No ClinGen
TOPMed
TCGA novel 162 E>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs12467132
CA59567675
164 A>D No ClinGen
Ensembl
rs1402256361
CA348883903
164 A>S No ClinGen
TOPMed
gnomAD
rs760452732
CA1959214
166 K>E No ClinGen
ExAC
gnomAD
CA348884055
rs1330673910
168 V>I No ClinGen
gnomAD
CA1959217
rs186344908
171 P>S No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA59567693
rs369947209
178 T>A No ClinGen
ESP
gnomAD
CA1959219
rs751610012
179 D>E No ClinGen
ExAC
gnomAD
rs753095047
CA1959222
182 I>T No ClinGen
ExAC
gnomAD
CA348884436
rs1253703360
183 L>F No ClinGen
TOPMed
gnomAD
CA1959223
rs756488413
184 F>L No ClinGen
ExAC
gnomAD
CA348885640
rs1162673929
187 D>N No ClinGen
TOPMed
gnomAD
rs1364389649
CA348885714
188 Y>C No ClinGen
gnomAD
CA348885814
COSM1009370
rs1419788745
191 K>N Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
rs753297385 193 N>K Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No NCI-TCGA
rs753297385 193 N>M Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No NCI-TCGA
CA348885924
rs1573961460
194 E>G No ClinGen
Ensembl
rs1338004524
CA348885947
195 E>G No ClinGen
gnomAD
CA1959249
rs745368217
196 R>G No ClinGen
ExAC
gnomAD
CA59568691
rs143377617
COSM106601
196 R>K skin [Cosmic] No ClinGen
cosmic curated
Ensembl
COSM108293
CA59568705
rs146255324
198 Q>K skin [Cosmic] No ClinGen
cosmic curated
Ensembl
rs139396181
COSM109894
CA59568713
199 N>K skin [Cosmic] No ClinGen
cosmic curated
Ensembl
TCGA novel 201 V>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1170235931
CA348886246
207 A>G No ClinGen
gnomAD
rs779383125
CA1959271
209 Q>H No ClinGen
ExAC
TOPMed
gnomAD
rs1227101487
CA348886295
209 Q>K No ClinGen
gnomAD
CA59568967
rs940739370
210 E>Q No ClinGen
TOPMed
rs139144686
CA1959272
210 E>V No ClinGen
ESP
ExAC
gnomAD
CA1959273
rs754892743
211 Q>* No ClinGen
ExAC
gnomAD
CA59568990
rs866315535
213 A>T No ClinGen
Ensembl
CA1959276
rs747940610
215 Q>E No ClinGen
ExAC
gnomAD
CA1959277
rs76002866
217 L>S No ClinGen
1000Genomes
ESP
TOPMed
gnomAD
rs1377932338
CA348886702
218 E>Q No ClinGen
gnomAD
CA1959279
rs145573186
219 E>D No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs142716482
CA1959280
220 D>A No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs368954177
CA1959281
221 A>G No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs772353316
CA1959282
222 E>D No ClinGen
ExAC
gnomAD
CA348886836
rs1336518068
223 M>T No ClinGen
gnomAD
CA1959324
rs768885266
226 L>Q No ClinGen
ExAC
gnomAD
rs201142063
CA1959323
226 L>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
1000Genomes
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA1959325
rs781186776
227 E>Q No ClinGen
ExAC
gnomAD
CA1959326
rs748264074
229 K>R No ClinGen
ExAC
gnomAD
CA59570378
rs374153062
232 C>Y No ClinGen
ESP
TOPMed
gnomAD
rs773826217
CA1959328
237 S>L No ClinGen
ExAC
TOPMed
CA348888639
rs1444030710
241 D>G No ClinGen
gnomAD
CA348888622
rs1291798115
241 D>N No ClinGen
TOPMed
rs771385009
CA1959330
244 T>I No ClinGen
ExAC
gnomAD
rs1247538983
CA348888741
246 R>G No ClinGen
TOPMed
rs4813
CA59570413
247 E>G No ClinGen
ESP
TOPMed
rs4813
CA59570414
247 E>V No ClinGen
ESP
TOPMed
CA1959331
rs774879990
248 D>N No ClinGen
ExAC
gnomAD
rs1296401220
CA348888824
250 H>Y No ClinGen
TOPMed
CA1959333
rs767282588
251 I>V No ClinGen
ExAC
gnomAD
CA348889091
rs571911479
258 E>* No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs763919441
CA1959336
258 E>D No ClinGen
ExAC
TOPMed
gnomAD
rs571911479
CA1959335
258 E>K No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1309326051
CA348889293
265 V>I No ClinGen
TOPMed
gnomAD
TCGA novel 269 K>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1028236877
CA348889406
270 E>* No ClinGen
gnomAD
rs1028236877
CA59570469
270 E>K Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
TCGA novel 271 G>E Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1323344081
CA348889703
274 L>V No ClinGen
gnomAD
CA1959349
rs746301438
276 K>E No ClinGen
ExAC
TOPMed
gnomAD
rs1029985868
CA59570906
282 A>T No ClinGen
TOPMed
CA348890182
rs1176724563
283 L>F No ClinGen
gnomAD
CA348890246
rs1268198088
284 G>V No ClinGen
gnomAD
CA1959351
rs775265757
287 K>R No ClinGen
ExAC
gnomAD
rs763617054
CA1959353
289 A>E No ClinGen
ExAC
gnomAD
rs776024514
CA348890550
292 G>A No ClinGen
ExAC
TOPMed
gnomAD
CA1959354
rs776024514
292 G>D No ClinGen
ExAC
TOPMed
gnomAD
rs761677581
CA348890755
297 R>S No ClinGen
ExAC
gnomAD
rs143840972
CA1959356
298 N>K No ClinGen
ESP
ExAC
gnomAD
rs750214755
CA1959357
300 E>V No ClinGen
ExAC
gnomAD
rs989775196
CA59571013
305 V>I No ClinGen
Ensembl
CA1959359
rs767702957
306 L>I No ClinGen
ExAC
gnomAD
CA1959360
rs533896111
307 E>G No ClinGen
1000Genomes
ExAC
gnomAD
rs1260510662
CA348891031
310 V>M No ClinGen
gnomAD
CA348891047
rs1268095950
311 E>G No ClinGen
TOPMed
rs777720784
CA1959361
312 K>E No ClinGen
ExAC
gnomAD
rs777853278
CA1959362
313 E>A Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA348891078
rs1204501885
313 E>K No ClinGen
gnomAD
CA1959364
rs757835858
314 A>V No ClinGen
ExAC
gnomAD
CA348891145
rs1197455395
316 K>R No ClinGen
gnomAD
CA348891277
rs1268463610
319 I>M No ClinGen
gnomAD
rs1194154895
CA348891348
320 E>D No ClinGen
gnomAD
rs1421436926
CA348891359
321 D>Y No ClinGen
gnomAD
TCGA novel 326 L>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA348891563
rs1308312482
327 N>K No ClinGen
TOPMed
rs1573963390
CA348891628
329 W>R No ClinGen
Ensembl
CA1959381
rs760886261
334 R>C No ClinGen
ExAC
TOPMed
gnomAD
CA348891958
rs760886261
334 R>G No ClinGen
ExAC
TOPMed
gnomAD
CA1959382
rs761080670
334 R>H No ClinGen
ExAC
gnomAD
rs753941499
CA1959383
335 R>S No ClinGen
ExAC
TOPMed
gnomAD
CA348891993
rs1573963543
335 R>T No ClinGen
Ensembl
CA1959386
rs757465425
337 K>T No ClinGen
ExAC
gnomAD
rs1244472114
CA348892237
341 K>R No ClinGen
gnomAD
rs1314437256
CA348892248
342 G>D No ClinGen
gnomAD
CA348892244
rs1284349421
342 G>S No ClinGen
TOPMed
TCGA novel 343 N>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA348892356
rs1304156691
344 K>N No ClinGen
TOPMed
CA348892347
rs1349178116
344 K>T No ClinGen
TOPMed
TCGA novel 346 A>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA348892413
rs1558973597
346 A>V No ClinGen
Ensembl
CA348892439
rs1558973605
347 Q>H No ClinGen
Ensembl
CA1959387
rs370543439
347 Q>P No ClinGen
ESP
ExAC
gnomAD
rs370543439
CA1959388
347 Q>R No ClinGen
ESP
ExAC
gnomAD
rs1390297049
CA348892461
349 G>R No ClinGen
TOPMed
rs374202019
CA59571188
349 G>V No ClinGen
ESP
TOPMed
CA1959389
rs758993474
352 K>Q No ClinGen
ExAC
TOPMed
gnomAD
CA1959390
rs780405113
354 K>R No ClinGen
ExAC
TOPMed
gnomAD
rs1237885774
CA348892704
356 Q>H No ClinGen
gnomAD
CA348892691
rs1255649253
356 Q>P No ClinGen
gnomAD
CA1959393
rs747335133
359 G>S No ClinGen
ExAC
TOPMed
gnomAD
rs780764356
CA1959396
362 T>K No ClinGen
ExAC
TOPMed
gnomAD
CA1959395
rs780764356
362 T>M No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 366 S>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1177202454
CA348892950
366 S>T No ClinGen
gnomAD
rs762821643
CA1959400
367 D>E No ClinGen
ExAC
gnomAD
CA1959399
rs772739645
367 D>G No ClinGen
ExAC
gnomAD
rs1558973669
CA348892963
367 D>H No ClinGen
Ensembl
CA1959401
rs377472931
368 D>G No ClinGen
ExAC
TOPMed
gnomAD
rs1377650498
CA348893027
369 E>K No ClinGen
gnomAD
rs1053269262
CA59571245
370 H>N No ClinGen
TOPMed
CA59571253
rs901363673
370 H>R No ClinGen
TOPMed
rs1350265055
CA348893094
371 D>G No ClinGen
gnomAD
rs575866793
CA1959403
372 E>Q No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA1959404
rs759308232
373 H>Y No ClinGen
ExAC
gnomAD
CA59571268
rs934249542
374 D>N No ClinGen
TOPMed
rs1201618687
CA348893170
375 E>A Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
CA1959405
rs139847090
375 E>K No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1201618687
CA348893175
375 E>V No ClinGen
TOPMed
gnomAD
rs1308557439
CA348893281
379 T>A Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
rs762159811
CA1959407
380 G>R No ClinGen
ExAC
TOPMed
gnomAD
CA348894333
rs1358250965
381 P>S No ClinGen
TOPMed
gnomAD
CA1959430
rs150765079
387 E>Q No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA1959431
rs773416649
389 T>K No ClinGen
ExAC
gnomAD
CA348894476
rs1338105682
391 K>R No ClinGen
gnomAD
CA1959435
rs766886435
395 A>T No ClinGen
ExAC
gnomAD
rs752046045
CA1959436
399 Q>K No ClinGen
ExAC
gnomAD
CA59571641
rs758688051
401 T>I No ClinGen
gnomAD
CA1959439
rs753066667
407 D>H No ClinGen
ExAC
gnomAD
rs957310075
CA348894788
408 Q>* No ClinGen
gnomAD
rs957310075
CA59571648
408 Q>K No ClinGen
gnomAD
CA1959441
rs777460087
408 Q>P No ClinGen
ExAC
gnomAD

No associated diseases with P05455

3 regional properties for P05455

Type Name Position InterPro Accession
domain RNA recognition motif domain 111 - 187 IPR000504
domain La-type HTH domain 7 - 99 IPR006630
domain La protein, xRRM domain 227 - 348 IPR014886

Functions

Description
EC Number
Subcellular Localization
  • Nucleus
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

4 GO annotations of cellular component

Name Definition
chromosome, telomeric region The end of a linear chromosome, required for the integrity and maintenance of the end. A chromosome telomere usually includes a region of telomerase-encoded repeats the length of which rarely exceeds 20 bp each and that permits the formation of a telomeric loop (T-loop). The telomeric repeat region is usually preceded by a sub-telomeric region that is gene-poor but rich in repetitive elements. Some telomeres only consist of the latter part (for eg. D. melanogaster telomeres).
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
ribonucleoprotein complex A macromolecular complex that contains both RNA and protein molecules.

6 GO annotations of molecular function

Name Definition
DNA binding Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).
mRNA binding Binding to messenger RNA (mRNA), an intermediate molecule between DNA and protein. mRNA includes UTR and coding sequences, but does not contain introns.
poly(U) RNA binding Binding to a sequence of uracil residues in an RNA molecule.
RNA binding Binding to an RNA molecule or a portion thereof.
sequence-specific mRNA binding Binding to messenger RNA (mRNA) of a specific nucleotide composition or a specific sequence motif.
tRNA binding Binding to a transfer RNA.

9 GO annotations of biological process

Name Definition
histone mRNA metabolic process The chemical reactions and pathways involving an mRNA encoding a histone.
IRES-dependent viral translational initiation Process by which viral mRNA translation is initiated, where a domain in the 5' untranslated region (UTR) of the viral mRNA called an internal ribosome entry site (IRES) binds the host 43S preinitiation complex, circumventing regular cap-dependent translation initiation.
nuclear histone mRNA catabolic process The chemical reactions and pathways resulting in the breakdown of histone messenger RNA (mRNA) within the nucleus.
protein localization to cytoplasmic stress granule A process in which a protein is transported to, or maintained in, a location within a cytoplasmic stress granule.
tRNA 3'-end processing The process in which the 3' end of a pre-tRNA molecule is converted to that of a mature tRNA.
tRNA 5'-leader removal Generation of the mature 5'-end of the tRNA, usually via an endonucleolytic cleavage by RNase P.
tRNA export from nucleus The directed movement of tRNA from the nucleus to the cytoplasm.
tRNA modification The covalent alteration of one or more nucleotides within a tRNA molecule to produce a tRNA molecule with a sequence that differs from that coded genetically.
tRNA processing The process in which a pre-tRNA molecule is converted to a mature tRNA, ready for addition of an aminoacyl group.

6 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q4G0J3 LARP7 La-related protein 7 Homo sapiens (Human) PR
Q71RC2 LARP4 La-related protein 4 Homo sapiens (Human) PR
Q6PKG0 LARP1 La-related protein 1 Homo sapiens (Human) PR
Q659C4 LARP1B La-related protein 1B Homo sapiens (Human) PR
Q05CL8 Larp7 La-related protein 7 Mus musculus (Mouse) PR
Q93ZV7 LA1 La protein 1 Arabidopsis thaliana (Mouse-ear cress) PR
10 20 30 40 50 60
MAENGDNEKM AALEAKICHQ IEYYFGDFNL PRDKFLKEQI KLDEGWVPLE IMIKFNRLNR
70 80 90 100 110 120
LTTDFNVIVE ALSKSKAELM EISEDKTKIR RSPSKPLPEV TDEYKNDVKN RSVYIKGFPT
130 140 150 160 170 180
DATLDDIKEW LEDKGQVLNI QMRRTLHKAF KGSIFVVFDS IESAKKFVET PGQKYKETDL
190 200 210 220 230 240
LILFKDDYFA KKNEERKQNK VEAKLRAKQE QEAKQKLEED AEMKSLEEKI GCLLKFSGDL
250 260 270 280 290 300
DDQTCREDLH ILFSNHGEIK WIDFVRGAKE GIILFKEKAK EALGKAKDAN NGNLQLRNKE
310 320 330 340 350 360
VTWEVLEGEV EKEALKKIIE DQQESLNKWK SKGRRFKGKG KGNKAAQPGS GKGKVQFQGK
370 380 390 400
KTKFASDDEH DEHDENGATG PVKRAREETD KEEPASKQQK TENGAGDQ